Publicaciones en colaboración con investigadores/as de Universidad de Alcalá (51)

2022

  1. Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa

    Cell Death and Disease, Vol. 13, Núm. 4

2021

  1. Effective glutamate clearance from the systemic circulation by hemodialysis: Potential relevance for cerebral ischemia management

    Artificial Organs, Vol. 45, Núm. 10, pp. 1183-1188

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Synthesis, Neuroprotection, and Antioxidant Activity of 1,1'-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models

    Molecules (Basel, Switzerland), Vol. 26, Núm. 4

  4. Tlr2 gene deletion delays retinal degeneration in two genetically distinct mouse models of retinitis pigmentosa

    International Journal of Molecular Sciences, Vol. 22, Núm. 15

2020

  1. Homo-tris-nitrones derived from α-phenyl-n-tert-butylnitrone: Synthesis, neuroprotection and antioxidant properties

    International Journal of Molecular Sciences, Vol. 21, Núm. 21, pp. 1-18

  2. Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 479-489

  3. Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma

    Brain Research Bulletin, Vol. 150, pp. 61-74

  4. Synthesis, neuroprotective and antioxidant capacity of PBN-related indanonitrones

    Bioorganic Chemistry, Vol. 86, pp. 445-451

2018

  1. Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa

    Molecular Neurodegeneration, Vol. 13, Núm. 1

2017

  1. Evaluation of a nanotechnology-based approach to induce gene-expression in human THP-1 macrophages under inflammatory conditions

    Immunobiology, Vol. 222, Núm. 2, pp. 399-408

  2. Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions

    Immunobiology, Vol. 222, Núm. 8-9, pp. 900-912

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 118, pp. 178-192

2015

  1. Increased levels of extracellular ATP in glaucomatous retinas: Possible role of the vesicular nucleotide transporter during the development of the pathology

    Molecular Vision, Vol. 21, pp. 1060-1070

  2. Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[18F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke

    European Journal of Medicinal Chemistry, Vol. 101, pp. 604-615

  3. Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease

    Future Medicinal Chemistry, Vol. 7, Núm. 7, pp. 845-855